Search Results - "Nigwekar, Sagar U"

Refine Results
  1. 1

    Calciphylaxis: Risk Factors, Diagnosis, and Treatment by Nigwekar, Sagar U., MD, MMSc, Kroshinsky, Daniela, MD, MPH, Nazarian, Rosalynn M., MD, Goverman, Jeremy, MD, Malhotra, Rajeev, MD, Jackson, Vicki Ann, MD, MPH, Kamdar, Mihir M., MD, Steele, David J.R., MD, Thadhani, Ravi I., MD, MPH

    Published in American journal of kidney diseases (01-07-2015)
    “…Calciphylaxis is a rare but devastating condition that has continued to challenge the medical community since its early descriptions in the scientific…”
    Get full text
    Journal Article
  2. 2

    A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors by Nigwekar, Sagar U, Zhao, Sophia, Wenger, Julia, Hymes, Jeffrey L, Maddux, Franklin W, Thadhani, Ravi I, Chan, Kevin E

    “…Accurate identification of risk factors for calcific uremic arteriolopathy (CUA) is necessary to develop preventive strategies for this morbid disease. We…”
    Get full text
    Journal Article
  3. 3

    Sodium Thiosulfate Therapy for Calcific Uremic Arteriolopathy by Sagar U. Nigwekar, Steven M. Brunelli, Debra Meade, Weiling Wang, Jeffrey Hymes, Eduardo Lacson, Jr

    “…Calcific uremic arteriolopathy (CUA) is an often fatal condition with no effective treatment. Multiple case reports and case series have described intravenous…”
    Get full text
    Journal Article
  4. 4

    Mortality and Serum Sodium: Do Patients Die from or with Hyponatremia? by Chawla, Arun, Sterns, Richard H, Nigwekar, Sagar U, Cappuccio, Joseph D

    “…Severe hyponatremia (<120 mEq/L) in hospitalized patients has a high mortality rate. We hypothesized that underlying diseases causing hyponatremia attribute to…”
    Get full text
    Journal Article
  5. 5

    Ergocalciferol and Cholecalciferol in CKD by Nigwekar, Sagar U., MD, Bhan, Ishir, MD, MPH, Thadhani, Ravi, MD, MPH

    Published in American journal of kidney diseases (01-07-2012)
    “…The development of chronic kidney disease (CKD) is accompanied by a progressive decrease in the ability to produce 1,25-dihydroxyvitamin D. Pharmacological…”
    Get full text
    Journal Article
  6. 6

    Calciphylaxis from Nonuremic Causes: A Systematic Review by Nigwekar, Sagar U, Wolf, Myles, Sterns, Richard H, Hix, John K

    “…Calciphylaxis, or calcific uremic arteriolopathy, is a well-described entity in end-stage kidney disease and renal transplant patients; however, little…”
    Get full text
    Journal Article
  7. 7

    Multidisciplinary approach to calcific uremic arteriolopathy by Nigwekar, Sagar U

    “…PURPOSE OF REVIEWCalcific uremic arteriolopathy (CUA), as known as calciphylaxis, is a rare and poorly understood disease seen predominantly in end stage renal…”
    Get full text
    Journal Article
  8. 8

    Delayed Denosumab Injections and Bone Mineral Density Response: An Electronic Health Record-based Study by Lyu, Houchen, Zhao, Sizheng S, Yoshida, Kazuki, Tedeschi, Sara K, Xu, Chang, Nigwekar, Sagar U, Leder, Benjamin Z, Solomon, Daniel H

    “…Abstract Context Discontinuation of denosumab leads to a rapid reversal of its therapeutic effect. However, there are no data regarding how unintended delays…”
    Get full text
    Journal Article
  9. 9

    Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis by Navaneethan, Sankar D, Nigwekar, Sagar U, Sehgal, Ashwini R, Strippoli, Giovanni F M

    “…Addition of aldosterone antagonists (AA) might provide renal benefits to proteinuric chronic kidney disease (CKD) patients over and above the inhibition of…”
    Get full text
    Journal Article
  10. 10

    Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use by Lyu, Houchen, Zhao, Sizheng S, Yoshida, Kazuki, Tedeschi, Sara K, Xu, Chang, Nigwekar, Sagar U, Leder, Benjamin Z, Solomon, Daniel H

    “…Teriparatide and denosumab are effective treatments for osteoporosis and typically reserved as second-line options after patients have used bisphosphonates…”
    Get full text
    Journal Article
  11. 11

    The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis by Chewcharat, Api, Chewcharat, Pol, Liu, Weitao, Cellini, Jacqueline, Phipps, Elizabeth A, Melendez Young, Jill A, Nigwekar, Sagar U

    Published in PloS one (14-07-2022)
    “…Dialysis patients have been shown to have low serum carnitine due to poor nutrition, deprivation of endogenous synthesis from kidneys, and removal by…”
    Get full text
    Journal Article
  12. 12

    Correlation between clinical and pathological features of cutaneous calciphylaxis by Dutta, Puja, Chaudet, Kristine M, Nazarian, Rosalynn M, Kroshinsky, Daniela, Nigwekar, Sagar U

    Published in PloS one (13-06-2019)
    “…Calciphylaxis is a rare and life-threatening disease that classically manifests with painful skin lesions. It occurs mainly in patients with end-stage renal…”
    Get full text
    Journal Article
  13. 13

    Hyponatremia, Mineral Metabolism, and Mortality in Incident Maintenance Hemodialysis Patients: A Cohort Study by Nigwekar, Sagar U., MD, Wenger, Julia, MPH, Thadhani, Ravi, MD, MPH, Bhan, Ishir, MD, MPH

    Published in American journal of kidney diseases (01-10-2013)
    “…Background Hyponatremia is associated with increased mortality in chronic diseases. Recent animal studies also implicate hyponatremia in bone abnormalities…”
    Get full text
    Journal Article
  14. 14

    Off-Pump Coronary Artery Bypass Surgery and Acute Kidney Injury: A Meta-analysis of Randomized and Observational Studies by Nigwekar, Sagar U., MD, Kandula, Praveen, MD, MPH, Hix, John K., MD, Thakar, Charuhas V., MD

    Published in American journal of kidney diseases (01-09-2009)
    “…Background Acute kidney injury (AKI) after coronary artery bypass grafting (CABG) is associated with significant morbidity and mortality. Controversy exists…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The Successful Use of Apixaban in Dialysis Patients with Calciphylaxis Who Require Anticoagulation: A Retrospective Analysis by Garza-Mayers, Anna C, Shah, Radhika, Sykes, David B, Nigwekar, Sagar U, Kroshinsky, Daniela

    Published in American journal of nephrology (01-01-2018)
    “…Calciphylaxis is a disease of dermal arteriolar calcification that results in necrosis. It commonly occurs in individuals with end-stage renal disease (ESRD)…”
    Get more information
    Journal Article
  17. 17

    The Treatment of Hyponatremia by Sterns, Richard H., MD, Nigwekar, Sagar U., MD, Hix, John Kevin, MD

    Published in Seminars in nephrology (01-05-2009)
    “…Summary Virtually all investigators now agree that self-induced water intoxication, symptomatic hospital-acquired hyponatremia, and hyponatremia associated…”
    Get full text
    Journal Article
  18. 18

    Optimal management of bone mineral disorders in chronic kidney disease and end stage renal disease by Lundquist, Andrew L, Nigwekar, Sagar U

    “…PURPOSE OF REVIEWThe review summarizes recent studies on chronic kidney disease–mineral bone disorders, with a focus on new developments in disease management…”
    Get full text
    Journal Article
  19. 19

    Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly by Ayus, Juan Carlos, Fuentes, Nora Angelica, Negri, Armando Luis, Moritz, Michael L, Giunta, Diego Hernan, Kalantar-Zadeh, Kamyar, Nigwekar, Sagar U, Thadhani, Ravi I, Go, Alan S, De Quiros, Fernan Gonzalez Bernaldo

    Published in Nephrology, dialysis, transplantation (01-10-2016)
    “…Hip fractures are among the most serious bone fractures in the elderly, producing significant morbidity and mortality. Several observational studies have found…”
    Get full text
    Journal Article
  20. 20